Aichi, Japan

Keiji Imai

This inventor holds 2 USPTO granted patents. Top assignee: Arax Co., Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiji Imai. Retrieved from https://idiyas.com/inventor/keiji-imai-vb66d59g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keiji Imai: Pharmaceutical Chemistry Patents

Introduction

Keiji Imai is an inventor associated with Aichi, Japan, and Arax Co., Ltd. His patent work includes chemical compounds and formulations described for pharmaceutical use. The available information lists 2 patents.

Latest Patents

Imai’s listed patents concern imidazoline and imidazole derivatives, including related forms and pharmaceutical applications.

- **Imidazoline derivative, possible tautomer thereof, and vulnerary.** This patent describes imidazoline derivatives and possible tautomeric forms, with substituents that may include nitrogen-containing aromatic rings or substituted phenyl groups. The disclosure also covers a vulnerary application.

- **Imidazole derivative, pharmaceutically acceptable salt thereof, and [title incomplete in the supplied data].** This patent describes imidazole derivatives and their pharmaceutically acceptable salts. Its claims outline variations in chemical substituents and structures, including oxygen- or sulfur-containing groups.

Career Highlights

The supplied information identifies Imai’s work with Arax Co., Ltd. and records two patents focused on medicinal chemistry. The patent descriptions indicate research into structurally varied imidazoline and imidazole compounds.

Collaborations

Eitaro Arakawa and Tsukasa Takamura are listed as Imai’s coworkers. The supplied information does not specify their roles in the patents.

Conclusion

Keiji Imai’s recorded patent portfolio reflects work on imidazoline and imidazole derivatives with potential pharmaceutical applications, developed in connection with Arax Co., Ltd.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…